https://www.rizerecovery.com/newsroom/arizona-naloxone-in-kind-settlement-2026 Rize Newsroom en 2026-09-17T13:48:17.883Z Arizona's New Naloxone Isn't a Gift — It's a Price Pharma Set for Itself https://www.rizerecovery.com/newsroom/stimulant-overdose-toolkit-gap Rize Newsroom en 2026-09-17T13:48:14.630Z The Overdose Toolkit We Built Doesn't Cover the Drugs Now Filling the Gap https://www.rizerecovery.com/newsroom/craving-strongest-predictor-relapse-2026 Rize Newsroom en 2026-09-17T13:48:11.614Z Craving, Not Willpower, Is What Actually Predicts Relapse https://www.rizerecovery.com/newsroom/seven-oh-ban-aftermath-substitution-2026 Rize Newsroom en 2026-09-17T13:48:08.711Z The Ban Landed. Tennessee Shows What Happens Next. https://www.rizerecovery.com/newsroom/telehealth-buprenorphine-last-minute-renewal-2026 Rize Newsroom en 2026-09-17T13:48:05.291Z Washington Keeps Rescuing Telehealth Bupe at the Last Minute. That's Not a Policy. https://www.rizerecovery.com/newsroom/poppers-treatment-gap-doctors-dont-ask Rize Newsroom en 2026-09-16T13:47:27.090Z The Treatment System Never Learned to Ask About Poppers https://www.rizerecovery.com/newsroom/psilocybin-trial-contingency-management-cocaine Rize Newsroom en 2026-09-16T13:47:23.855Z A New Psilocybin Trial Won't Save Anyone This Year — Contingency Management Already Could https://www.rizerecovery.com/newsroom/norway-heroin-assisted-treatment-ceasefire-not-cure Rize Newsroom en 2026-09-16T13:47:20.625Z Norway's Heroin Program Isn't a Cure — It's the Ceasefire That Makes Recovery Possible https://www.rizerecovery.com/newsroom/fda-psychedelics-hearing-va-veterans-left-behind Rize Newsroom en 2026-09-16T13:47:17.252Z Washington Is Sprinting to Approve Psychedelics. It Left the VA at the Starting Line.